Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12615001299594Phase 4Recruiting
Phase 4, open-label trial of oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Monash Health. Primary endpoint: Neonatal arterial oxygen saturation. Started Mar 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12615001299594.